SCHEMBL7549043

SCHEMBL7549043

COC(=O)c1cc(CNC(=O)OC(C)(C)C)ccc1NC(=O)CC1CCc2cc(Cl)cc3[nH]c(C(=O)OC)c1c23

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.33
MTNR1B P49286 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
GAA P10253 1/20 0.32
CACNA1B Q00975 1/20 0.32
ROCK2 O75116 1/20 0.32
NAMPT P43490 1/20 0.31
THRB P10828 1/20 0.31
FPR3 P25089 1/20 0.31
FPR2 P25090 1/20 0.31
ATR Q13535 1/20 0.30
MAPT P10636 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
KDM4E B2RXH2 2/20 0.30
ALDH1A1 P00352 2/20 0.30
HPGD P15428 1/20 0.30
PRMT5 O14744 1/20 0.30
WDR77 Q9BQA1 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7548639 0.96 MTNR1A (0.32) MTNR1AMTNR1BL3MBTL1GAACACNA1B
SCHEMBL7554008 0.91 FPR3 (0.36) MTNR1AMTNR1BL3MBTL1GAACACNA1B
SCHEMBL7547267 0.90 MTNR1A (0.32) MTNR1AMTNR1BL3MBTL1CACNA1BROCK2
SCHEMBL7550462 0.90 MTNR1A (0.32) MTNR1AMTNR1BL3MBTL1ROCK2NAMPT
SCHEMBL7547391 0.89 MAPT (0.33) MTNR1AMTNR1BL3MBTL1MAPTTDP1
SCHEMBL7554385 0.87 GLS (0.30) MTNR1AMTNR1B
SCHEMBL7547784 0.87 MTNR1A (0.34) MTNR1AMTNR1BL3MBTL1CACNA1BNAMPT
SCHEMBL7549035 0.87 MTNR1A (0.36) MTNR1AMTNR1BL3MBTL1CACNA1BMAPT
SCHEMBL7555174 0.85 MTNR1A (0.34) MTNR1AMTNR1BMAPTKDM4EALDH1A1
SCHEMBL7548916 0.84 GRIN1 (0.32) L3MBTL1ROCK2NAMPTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0657427-B1 Tricyclic indole-2-carboxylic acid derivatives being selective antagonists of the NMDA receptor SUMITOMO PHARMA (JP) 2002-06-19 EP disclosed
US-5496843-A Tricyclic indole-2-carboxylic acid derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-03-05 US disclosed
EP-0657427-A1 Tricyclic indole-2-carboxylic acid derivatives being selective antagonists of the NMDA receptor SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1995-06-14 EP disclosed